Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genus PLC (GB:GNS)
LSE:GNS
GNS Stock Chart & Stats
Day’s Range― - ―
52-Week Range1,424.00p - 2,155.00p
Previous CloseN/A
Volume9.41K
Average Volume (3M)125.25K
Market Cap
£1.15B
Enterprise Value1.33B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)145.8
Beta1.50
Next Earnings
Feb 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 07, 2024Dividend Yield1.8%
Share Statistics
EPS (TTM)0.12
Shares Outstanding66,036,290
10 Day Avg. Volume86,898
30 Day Avg. Volume125,251
Standard Deviation0.10
R-Squared0.02
Alpha-0.00342
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.75
Price to Cash Flow (P/CF)24.60
P/FCF Ratio24.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
1,912.50pPrice Target Upside7.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Genus plc News
PremiumCompany Announcements
Genus plc Updates on Total Voting Rights
PremiumCompany Announcements
Genus Exceeds Expectations with Strong First Half Performance
PremiumCompany Announcements
Genus plc Reports Successful AGM with Shareholder Engagement
PremiumCompany Announcements
Genus plc Reports Strong Growth Amid Currency Challenges
PremiumCompany Announcements
Genus plc Reports Total Voting Rights UpdatePremiumCompany Announcements
Genus plc CFO to Retire, Successor Search Underway
PremiumCompany Announcements
Genus plc Announces 2024 AGM and Report Availability---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company reported better-than-expected performance in the first half of FY25, with significant growth in adjusted profit before tax.
Growth PotentialThe execution of VAP Phase 2 is on track, expected to further help ABS deliver significant profit growth.
Market ExpectationsGenus has announced that adjusted profit before tax for the first half of FY25 will be at least £35m, which is ahead of expectations.
Bears Say
Economic ConcernsThere is caution due to continued economic weakness in China and the possibility of tariff wars, which could impact the business negatively.
Market SentimentThe stock rating has been downgraded from Buy to Hold due to weaker sentiment and a cautious outlook.
Regulatory ChallengesUncertainty exists due to important regulatory and commercial hurdles for the PRP programme, affecting near-term confidence.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.31% Insiders
13.93% Mutual Funds
― Other Institutional Investors
77.83% Public Companies and
Individual Investors
GNS FAQ
What was Genus PLC’s price range in the past 12 months?
Genus PLC lowest share price was 1424.00p and its highest was 2155.00p in the past 12 months.
What is Genus PLC’s market cap?
Genus PLC’s market cap is £1.15B.
When is Genus PLC’s upcoming earnings report date?
Genus PLC’s upcoming earnings report date is Feb 27, 2025 which is in 5 days.
How were Genus PLC’s earnings last quarter?
Genus PLC released its earnings results on Sep 05, 2024. The company reported -0.085p earnings per share for the quarter, missing the consensus estimate of N/A by -0.085p.
Is Genus PLC overvalued?
According to Wall Street analysts Genus PLC’s price is currently Undervalued.
Does Genus PLC pay dividends?
Genus PLC pays a Annually dividend of 31.999p which represents an annual dividend yield of 1.8%. See more information on Genus PLC dividends here
What is Genus PLC’s EPS estimate?
Genus PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genus PLC have?
Genus PLC has 66,036,290 shares outstanding.
What happened to Genus PLC’s price movement after its last earnings report?
Genus PLC reported an EPS of -0.085p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.676%.
Which hedge fund is a major shareholder of Genus PLC?
Currently, no hedge funds are holding shares in GB:GNS
---
Genus plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
1,912.50p (7.69% Upside)
1,912.50p (7.69% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.58%
12-Months-Change
Fundamentals
Return on Equity
1.41%
Trailing 12-Months
Asset Growth
2.12%
Trailing 12-Months
Company Description
Genus PLC
Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. The company generates most of its revenue from its porcine exposure, followed by its bovine exposure. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency.
---
GNS Stock 12 Month Forecast
Average Price Target
1,912.50p
▲(7.69% Upside)
Technical Analysis
Associated British Foods
―
Croda International
―
FDM Group (Holdings)
―
Halma plc
―
PZ Cussons
―
Best Analysts Covering GNS
1 Year
1 Year Success Rate
3/5 ratings generated profit
1 Year Average Return
-3.38%
reiterated a buy rating 3 months ago
Copying Patrick Roquas's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -3.38% per trade.
---